Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.60 |
| ▸ | MME | P08473 | 3/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MMP7 | P09237 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP12 | P39900 | 1/20 | 0.57 |
| ▸ | MMP13 | P45452 | 1/20 | 0.57 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
| ▸ | CPA1 | P15085 | 1/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31611867 | 0.95 | LTA4H (0.56) | LTA4HMME | |
| SCHEMBL27983689 | 0.95 | LTA4H (0.64) | LTA4HMME | |
| SCHEMBL30386347 | 0.93 | BACE1 (0.60) | LTA4HMMEMMP2MMP7MMP9 | |
| SCHEMBL30050978 | 0.92 | LTA4H (0.63) | LTA4HMMEMMP2MMP7MMP9 | |
| SCHEMBL30051692 | 0.92 | LTA4H (0.67) | LTA4HMMEMMP2MMP7MMP9 | |
| SCHEMBL30385451 | 0.92 | BACE1 (0.59) | LTA4HMMP2MMP7MMP9MMP12 | |
| SCHEMBL30799804 | 0.91 | OPRM1 (0.60) | LTA4HMME | |
| SCHEMBL30473791 | 0.90 | FOLH1 (0.65) | MMEACECPA1ACE2 | |
| SCHEMBL31602914 | 0.90 | LTA4H (0.57) | LTA4HMMEMMP2MMP7MMP9 | |
| SCHEMBL31482433 | 0.90 | LTA4H (0.57) | LTA4HMMEMMP2MMP7MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5500208-A | Oral compositions comprising a novel tripeptide | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| WO-1995033764-A2 | ORAL COMPOSITIONS COMPRISING A NOVEL TRIPEPTIDE | PROCTER & GAMBLE (US) | 1995-12-14 | — | — | WO | disclosed |